Computational Simulation and Molecular Docking: Applications in the Field of Drug Discovery and Development

DUPHAT Webinars

May 25, 2021 - 16:00 - 17:00

Topic Description :

Computational Simulation and Molecular Docking: Applications in the Field of Drug Discovery and Development

Learning Objectives:

  1. Recognize the importance of computational and molecular docking in the field of drug design and drug discovery
  2. Describe some applications of molecular docking studies in drug discovery

Speaker :

Dr. Ahmed Thabet Negmeldin

Dr. Ahmed Thabet Negmeldin

Chair and Assistant Professor, Department of Pharmaceutical Sciences,
Program Director, Master of Science in Drug Discovery and Development (MDD),
College of Pharmacy – Gulf Medical University

Bio:

Dr. Ahmed Thabet graduated from Faculty of Pharmacy, Cairo University, Cairo, Egypt with a bachelor degree in pharmacy and pharmaceutical sciences with honors in 2006. He was hired as a demonstrator at the same university where he received his master’s degree in pharmaceutical organic chemistry in 2011. Dr. Ahmed received his Ph.D. from Wayne State University, Detroit, MI, USA, in 2017 where he worked with Mary Kay Pflum on the design, synthesis, molecular docking and biological screening of several small molecules targeting different HDAC isoforms as anti-cancer agents. Later he joined College of Pharmacy, Gulf Medical University as an assistant professor of medicinal chemistry in 2018 and is currently serving as chair of the department of pharmaceutical sciences since April 2019. Dr. Ahmed has more than 13 years of research experience in drug design, medicinal chemistry, organic chemistry, chemical synthesis, molecular docking, and biological screening of inhibitors. He also has 13 years of teaching experience at different universities in the US, Egypt, and UAE. He is a recipient of 7 awards Wayne State University for outstanding research and/or academic records and 3 awards at for excellence in teaching. His research interest is rational design and computer-aided drug design of anti-cancer agents.

Organised By